Abstract:Introduction: Pulmonary tuberculosis (PTB) remains one of the deadliest infectious diseases. Understanding PTB immunity is of potential value for exploring immunotherapy for treating chemotherapy-resistant PTB. CD4 + CD25 + Foxp3 + regulatory T cells (Tregs) are key players that impair immune responses to Mycobacteria tuberculosis (MTB). Currently, the intrinsic factors governing Treg expansion and influencing the immunosuppressive attributes of Tregs in PTB patients are far from clear. Methods: Here, we employed flow cytometry to determine the frequency of Tregs and the expression of B and T lymphocyte attenuator (BTLA) and its ligand, herpesvirus entry mediator (HVEM), on Tregs in patients with active PTB. Furthermore, the expression of conventional T cells and of programmed death-ligand 1 (PD-L1) and programmed death-1 (PD-1) on Tregs in patients with active PTB was determined. We then examined the characteristics of BTLA/HVEM expression and its correlation with Treg frequency and PD-L1 and PD-1 expression on Tregs in PTB patients. Results: The frequency of Tregs was increased in PTB patients and it had a relevance to PTB progression. Intriguingly, the axis of cosignal molecules, BTLA and HVEM, were both downregulated on the Tregs of PTB patients compared with healthy controls (HCs), which was the opposite of their upregulation on conventional T cells. Unexpectedly, their expression levels were positively correlated with the frequency of Tregs, respectively. These seemingly contradictory results may be interpreted as follows: the downregulation of BTLA and HVEM may alleviate BTLA/HVEM cis -interaction-mediated coinhibitory signals pressing on naïve Tregs, helping their activation, while the BTLA/HVEM axis on effector Tregs induces a costimulatory signal, promoting their expansion. Certainly, the mechanism underlying such complex effects remains to be explored. Additionally, PD-L1 and PD-1, regarded as two of the markers characterizing the immunosuppressive attributes and differentiation potential of Tregs, were upregulated on the Tregs of PTB patients. Further analysis revealed that the expression levels of BTLA and HVEM were positively correlated with the frequency of PD-1 + Tregs and PD-L1 + Tregs, respectively. Conclusion: Our study illuminated distinct characteristics of BTLA/HVEM axis expression on Tregs and uncovered its impact on the expansion and attributes of Tregs in patients with active PTB. Therefore, blockade of the BTLA/HVEM axis may be a promising potential pathway to reduce Treg expansion for the improvement of anti-MTB immune responses.

Basic leucine zipper ATF-like transcription factor involvement in regulating the immune pathogenesis of tuberculosis

BATF Potentially Mediates Negative Regulation of PD-1/PD-Ls Pathway on T Cell Functions in Mycobacterium tuberculosis Infection

Expression and Clinical Significance of B and T Lymphocyte Attenuator on CD4+ and CD8+ T Cells from Patients with Pulmonary Tuberculosis.

The characteristic profiles of PD-1 and PD-L1 expressions and dynamic changes during treatment in active tuberculosis

BTLA exhibits immune memory for alpha beta T cells in patients with active pulmonary tuberculosis

Distinct characteristics of BTLA/HVEM axis expression on Tregs and its impact on the expansion and attributes of Tregs in patients with active pulmonary tuberculosis

STAT3 Regulation of Mtb-specific T Cell Function in Active Pulmonary Tuberculosis Patients.

Characterization of cytokine profile to distinguish latent tuberculosis from active tuberculosis and healthy controls.

BTLA exhibits immune memory for αβ T cells in patients with active pulmonary tuberculosis.

The elevated expression of LAG-3 on CD8+T cells correlates with disease severity of pulmonary TB

Progress on Diagnosis and Treatment of Latent Tuberculosis Infection

PD-1/PD-L pathway inhibits M . tb -specific CD4 + T-cell functions and phagocytosis of macrophages in active tuberculosis

Modulatory effect of Tim-3/Galectin-9 axis on T-cell-mediated immunity in pulmonary tuberculosis

CTLA-4 Blockade Reverses the Foxp3+ T-regulatory-cell Suppression of Anti-Tuberculosis T-cell Effector Responses

B Cell–Activating Transcription Factor Plays a Critical Role in the Pathogenesis of Anti–Major Histocompatibility Complex–Induced Obliterative Airway Disease

The Role of β-Catenin in Th1 Immune Response against Tuberculosis and Profiles of Expression in Patients with Pulmonary Tuberculosis

Elevated Expression of T-bet in Mycobacterial Antigen-Specific CD4(+) T Cells from Patients with Tuberculosis.

Cd4(+)Cd25(+)Foxp3(+) Regulatory T Cells Suppress Mycobacterium Tuberculosis Immunity in Patients with Active Disease

BATF controls IFN I production via DC-SCRIPT in plasmacytoid dendritic cells

The presence of cytotoxic CD4 and exhausted-like CD8+ T-cells is a signature of active tuberculosis